Tag: Y-90 resin microspheres

Sirtex Medical

Sirtex Medical and Grand Pharmaceutical Group Limited granted NDA approval of...

Sirtex Medical has announced with Grand Pharmaceutical Group Limited, that SIR-Spheres Y-90 resin microspheres have been approved by the national medical products administration (NMPA)...

Personalised treatment planning “the future” of radioembolization, ECIO hears, in Y-90...

Personalised treatment selection and planning based on controlled dosimetry will lead to improvements in treatment accuracy. This is the conclusion presented by Marnix Lam...
Interventional News for specialists

BTG launches βETA radiation safety programme at CIRSE 2016

BTG has launched the βETA Radiation Safety Programme, a new initiative designed to reduce the risk of radiation exposure when performing selective internal radiation...